Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
MASI: Stock Quote & Summary Data
0.26%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 402,790 |
| Previous Close | $ 26.80 |
| 52 Wk High / Low | $ 31.28 / $ 21 |
| Shares Outstanding | 57,706,000 |
| Market Value | $ 1,550,560,220 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.99 |
| NASDAQ Official Open Price: | $ 26.57 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 26.87 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About MASI?
Ask your question about about Masimo Corporation (MASI) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a global medical technology company that develops, manufactures and markets non-invasive patient monitoring products that improve patient care. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996. We invented Masimo Signal Extraction Technology, or Masimo SET, which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Pulse oximetry is the non-invasive measurement of the oxygen saturation level of arterial blood, or the blood that delivers oxygen to the body’s tissues, and pulse rate. Our Masimo SET platform has addressed many of the previous technology limitations and has been referred to by several industry sources as the gold standard in pulse oximetry. The benefits of Masimo SET have been validated in over 100 independent clinical and laboratory studies. During fiscal 2007, we generated product revenue of $199. ... More ...
Links to all Masimo Corporation (MASI) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for MASI |
||
|
Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference - PR Newswire 11/20/2009 8:00AM |
||
|
Masimo, CareFusion Ink Technology Licensing Deal For Masimo Rainbow SET Pulse CO-Oximetry - Quick Facts - RTT News 11/12/2009 8:29AM |
||
|
CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) - PR Newswire 11/12/2009 8:00AM |
||
|
Masimo to Present at the Lazard Capital Markets 6th Annual Healthcare Conference - PR Newswire 11/10/2009 8:00AM |
||
|
New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood - PR Newswire 11/05/2009 8:00AM |
||
|
Masimo Q3 Profit Marginally Declines - Quick Facts - RTT News 11/03/2009 5:28PM |
||
|
Masimo Reports Third Quarter 2009 Financial Results - PR Newswire 11/03/2009 4:00PM |
